SG7 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - SAGE Therapeutics Inc

Watchlist Manager

Watchlist

Price: 7.598 EUR 1.12%

Market Cap: €457.3m

S	SAGE Therapeutics Inc SWB:SG7	US
M	Muthoot Finance Ltd BSE:533398	IN
	Opawica Explorations Inc F:OE5	CA
	Hokuriku Electric Power Co OTC:HOKRF	JP
	PG&E Corp NYSE:PCG	US
	Scholar Rock Holding Corp F:2QK	US
M	MorphoSys AG DUS:MOR	DE
G	Geely Automobile Holdings Ltd DUS:GRU	HK
M	MorphoSys AG XHAM:MOR	DE
	Surya Citra Media Tbk PT IDX:SCMA	ID
E	Edison International XMUN:EIX	US
H	Hanjaya Mandala Sampoerna Tbk PT XBER:HSZ	ID
I	Iluka Resources Ltd F:ILZ	AU
	Addtech AB OTC:ADDHY	SE

Profitability Summary

SAGE Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Strong 3Y Average Gross Margin

80%

Negative Operating Margin

-430%

Negative 3Y Average Operating Margin

-1 778%

Operating Margin is Increasing

-5 975% > -430%

Negative Net Margin

-428%

Negative 3Y Average Net Margin

-1 727%

Net Margin is Increasing

-5 688% > -428%

Negative Free Cash Flow Margin

-411%

Negative 3Y Average Free Cash Flow Margin

-1 491%

Free Cash Flow Margin is Increasing

-5 114% > -411%

Negative ROE

-60%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-750%

ROIC is Increasing

-814% > -616%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.